Cloughesy TF - Search Results

1

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS. Choe G, et al. Among authors: cloughesy tf. Clin Cancer Res. 2002 Sep;8(9):2894-901. Clin Cancer Res. 2002. PMID: 12231534

2

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Liau LM, et al. Among authors: cloughesy tf. J Neurosurg. 1999 Jun;90(6):1115-24. doi: 10.3171/jns.1999.90.6.1115. J Neurosurg. 1999. PMID: 10350260

3

Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.

Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR. Gupta RK, et al. Among authors: cloughesy tf. J Neurooncol. 2000 Dec;50(3):215-26. doi: 10.1023/a:1006431120031. J Neurooncol. 2000. PMID: 11263501

4

Targeted molecular therapy of GBM.

Mischel PS, Cloughesy TF. Mischel PS, et al. Among authors: cloughesy tf. Brain Pathol. 2003 Jan;13(1):52-61. doi: 10.1111/j.1750-3639.2003.tb00006.x. Brain Pathol. 2003. PMID: 12580545 Free PMC article. Review.

5

Identification of molecular subtypes of glioblastoma by gene expression profiling.

Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF. Mischel PS, et al. Among authors: cloughesy tf. Oncogene. 2003 Apr 17;22(15):2361-73. doi: 10.1038/sj.onc.1206344. Oncogene. 2003. PMID: 12700671

6

Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.

Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS. Choe G, et al. Among authors: cloughesy tf. Cancer Res. 2003 Jun 1;63(11):2742-6. Cancer Res. 2003. PMID: 12782577

7

Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.

Mischel PS, Nelson SF, Cloughesy TF. Mischel PS, et al. Among authors: cloughesy tf. Cancer Biol Ther. 2003 May-Jun;2(3):242-7. doi: 10.4161/cbt.2.3.369. Cancer Biol Ther. 2003. PMID: 12878856 Free article. Review.

8

Gene expression profiling identifies molecular subtypes of gliomas.

Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Shai R, et al. Among authors: cloughesy tf. Oncogene. 2003 Jul 31;22(31):4918-23. doi: 10.1038/sj.onc.1206753. Oncogene. 2003. PMID: 12894235

9

Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.

Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Lu KV, et al. Among authors: cloughesy tf. Lab Invest. 2004 Jan;84(1):8-20. doi: 10.1038/sj.labinvest.3700003. Lab Invest. 2004. PMID: 14631378

10

p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition.

Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel PS. Wang Y, et al. Among authors: cloughesy tf. Oncogene. 2004 Feb 12;23(6):1283-90. doi: 10.1038/sj.onc.1207244. Oncogene. 2004. PMID: 14961077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters